Gavi applauds MSF’s effort to break Pfizer vaccine monopoly in India

News December 29, 2017

Anuradha Gupta, Deputy CEO of the vaccine alliance Gavi, says Médecins Sans Frontières (MSF)’s legal challenge of a Pfizer patent in India could, if successful, contribute to making the pharmaceutical market more “healthy.” Revoking the patent would break Pfizer’s monopoly on pneumonia vaccine, opening the way for cheaper generic copies to enter the market.

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.

Gavi applauds MSF’s effort to break Pfizer vaccine monopoly in India

Tags: